Spegra is a combination medicine used to treat HIV infection.
It contains three medicines in one tablet:
-
Dolutegravir (DTG)
-
Emtricitabine (FTC)
-
Tenofovir alafenamide (TAF)
This “single pill” makes HIV treatment easier and more effective.
Mechanism
-
Dolutegravir: Blocks an enzyme called integrase, which the HIV virus uses to insert its genetic material into human cells.
-
Emtricitabine & Tenofovir alafenamide: Block another enzyme called reverse transcriptase, which HIV needs to make copies of itself.
-
Together, these actions stop HIV from multiplying and reduce the amount of virus in the blood.
Uses
-
Treatment of HIV-1 infection in adults and adolescents (as prescribed by a doctor).
-
Helps strengthen the immune system, reduce HIV-related complications, and improve quality of life.
Adverse Effects
Common side effects:
-
Headache
-
Tiredness
-
Trouble sleeping
-
Nausea, diarrhea
-
Weight gain (sometimes with Dolutegravir)
-
-




